"We did not meet our financial goals in 2024, and that's reflected in our corporate bonus," a company representative told ...
Companies inform investors of possible business risks from Trump's government changes, tucking warnings into extensive "risk ...
President Trump's government overhaul in annual reports, highlighting risks from tariffs to healthcare reforms.
CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback